By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Cephalosporin > Ceftriaxone

Ceftriaxone

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|653 words

Ceftriaxone: Antibiotic Drug Profile

What is Ceftriaxone?

Ceftriaxone is a broad-spectrum antibiotic that belongs to the third-generation cephalosporin class of medications. It is a prescription medication used to treat serious bacterial infections throughout the body, including infections of the respiratory tract, urinary tract, skin, and bloodstream. Ceftriaxone is administered by injection or intravenous infusion and is particularly valued for its long half-life, allowing for once or twice-daily dosing.

Uses

Ceftriaxone is prescribed for several serious bacterial infections:

  • Pneumonia and respiratory tract infections: Effective against bacterial pneumonia caused by susceptible organisms, including community-acquired pneumonia
  • Meningitis: Used as first-line treatment for bacterial meningitis, particularly when caused by pneumococcus or meningococcus
  • Sepsis and bloodstream infections: Treats life-threatening bacterial infections that have spread to the blood
  • Gonorrhea: Single-dose treatment for uncomplicated gonorrheal infections
  • Intra-abdominal infections: Used for complicated infections within the abdomen, often in combination with other antibiotics
  • Surgical prophylaxis: Prevents bacterial infections during certain surgical procedures

How it works

Ceftriaxone works by interfering with bacterial cell wall synthesis, specifically targeting enzymes called penicillin-binding proteins that are essential for building the bacterial cell wall. When bacteria cannot properly construct their cell walls, they become weakened and eventually die. This mechanism makes ceftriaxone effective against a wide range of gram-positive and gram-negative bacteria, though it is particularly active against gram-negative organisms.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Pain, swelling, or irritation at injection site
  • Diarrhea
  • Nausea and vomiting
  • Headache
  • Dizziness
  • Rash or skin irritation
  • Elevated liver enzymes
  • Changes in blood cell counts

Serious side effects requiring immediate medical attention:

  • Severe allergic reactions (anaphylaxis) with difficulty breathing or swelling
  • Clostridioides difficile-associated diarrhea (severe, persistent diarrhea)
  • Gallbladder problems, including gallstones (biliary sludge)
  • Severe skin reactions such as Stevens-Johnson syndrome
  • Kidney problems or changes in urination

Warnings and precautions

  • Allergy history: Patients with known allergies to penicillin or other cephalosporins may be at increased risk for allergic reactions to ceftriaxone
  • Pregnancy and breastfeeding: Generally considered safe during pregnancy when benefits outweigh risks, but should be used with caution; small amounts pass into breast milk
  • Kidney and liver function: Dosage adjustments may be necessary in patients with severe kidney or liver impairment, though ceftriaxone is eliminated through both kidneys and liver
  • Neonates and calcium: Should not be given with calcium-containing solutions in newborns due to risk of precipitation in lungs and kidneys
  • Gallbladder effects: Can cause reversible gallbladder sludge, particularly with high doses or prolonged treatment

Interactions

  • Calcium-containing solutions: Can form potentially fatal precipitates when mixed, particularly dangerous in neonates and infants
  • Warfarin and anticoagulants: May enhance bleeding effects by affecting vitamin K-producing gut bacteria and protein binding
  • Aminoglycosides: Combination may increase risk of kidney toxicity, though sometimes used together for enhanced bacterial coverage
  • Probenecid: Can increase ceftriaxone blood levels by blocking kidney elimination, potentially requiring dose adjustment
  • Live bacterial vaccines: Ceftriaxone may reduce effectiveness of live bacterial vaccines such as typhoid vaccine
  • Alcohol: While not causing a disulfiram-like reaction, alcohol may worsen gastrointestinal side effects
  • Loop diuretics: Concurrent use may increase risk of kidney toxicity, especially in elderly patients

Check interactions with the GMJ Interaction Checker

Dosage

Ceftriaxone dosing varies significantly based on the type and severity of infection being treated. For adults, typical doses range from 1 to 2 grams given once or twice daily by intravenous or intramuscular injection. For uncomplicated gonorrhea, a single 250mg intramuscular dose is standard. In severe infections such as meningitis, doses up to 4 grams daily may be used. Treatment duration typically ranges from 4 to 14 days depending on the infection type and patient response. Dosage adjustments are generally not required for mild to moderate kidney or liver impairment, but careful monitoring is recommended. All dosing decisions should be made by a qualified healthcare provider based on individual patient factors and infection characteristics.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Ceftriaxone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/ceftriaxone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Scientists Discover Master Clock That Controls Biological Growth and Development

Scientists have identified a genetic master clock that controls biological development timing.…

Brain immune cells reveal why some people resist dementia despite tau tangles

New Nature Medicine research reveals how brain immune cells determine whether people…

Climate Change Disrupts Education for 617 Million Children in Poverty Worldwide

Climate change is systematically disrupting education for 617 million children worldwide, with…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Cefalexin

By
Prof. Giorgi Pkhakadze
02/06/2026

Cefuroxime

By
Prof. Giorgi Pkhakadze
02/06/2026

Ceftazidime

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up